Replies to post #569433 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Thanks WW.

In my opinion, Linda has to offer much more clarity than what was offered at the ASM. If the optimization process has major hurdles and takes too long, bleeding into 2024, this will likely impact valuations for any BP transaction. And add additional costs that shareholders will incur due to continued reliance on the manual process.